We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated MRI Accurately Diagnoses Parkinson's Disease

By HospiMedica International staff writers
Posted on 09 Sep 2019
A new study suggests that diffusion-weighted magnetic resonance imaging (MRI) can distinguish between Parkinsonian syndromes using an automated imaging approach.

Researchers at the University of Florida (UF, Gainesville, USA), the University of Michigan (U-M; Ann Arbor, USA), and other institutions conducted an international study at 17 MRI centers in Austria, Germany, and the USA involving 1,002 patients in order to develop and validate an automated system that accurately diagnoses Parkinson's disease (PD) and other related, but different, neurodegenerative disorders.

The researchers used 60 template regions and tracts of interest in order to teach a machine-learning (ML) algorithm the difference between PD, atypical Parkinsonism (i.e., multiple system atrophy and progressive supranuclear palsy), multiple system atrophy, and progressive supranuclear palsy. More...
For each comparison, a training and validation cohort was evaluated in an independent test cohort. The primary outcomes were free water and free-water-corrected fractional anisotropy across the different template regions.

The results revealed that a combination of diffusion-weighted MRI and Movement Disorders Society Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS III) rank is capable of differentiating forms of Parkinson’s. The 10 regions with greatest relative importance to the model were those previously shown to be pathologically involved in PD, multiple system atrophy, and progressive supranuclear palsy. The researchers also developed a region of interest template and three white matter tractography templates. The study was published on August 27, 2019, in The Lancet Digital Health.

“Our method may help to reduce the number of misdiagnosed cases in the future. Since these diseases require unique treatment plans and different medications, and clinical trials testing new medications require the correct diagnosis, getting it right is important for patient care,” said lead author Professor David Vaillancourt, PhD, of the UF departments of applied physiology and kinesiology. “The diffusion-weighted MRI method does not involve radioactive tracers, is completely automated, and can be collected in less than 12 minutes across 3T MRI scanners worldwide.”

Related Links:
University of Florida
University of Michigan


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hypodermic Syringe
SurTract™ Safety Syringe
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.